Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 66 (KRT18P66) is a processed pseudogene with high sequence similarity to the functional keratin 18 (KRT18) gene. Pseudogenes like KRT18P66 do not encode functional proteins and have no known biological function, disease association, or therapeutic relevance. A large number of pseudogenes related to keratin 18 exist in the human genome as non-functional remnants arising from gene duplication and retrotransposition events. Nearly 90% of keratin-related pseudogenes relate specifically to keratins 8 and 18[3]. KRT18P66 is a pseudogene, not a druggable target, and has no known biological role or value as a therapeutic target, biomarker, or drug-interacting entity. If you were searching for the functional gene/protein, refer to "Keratin 18" (KRT18) instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 66 (KRT18P66).